Hardman Johnston Global Advisors’s Elevance Health ELV Stock Holding History

Hardman Johnston Global Advisors’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-17,588	Closed	-$6.84M	–	74
2025 Q2	$6.84M	Buy	+17,588	New	+$7.07M	0.3%	46
2025 Q1	–	Sell	-20,020	Closed	-$7.39M	–	76
2024 Q4	$7.39M	Sell	20,020 -1,138	-5%	-$476K	0.3%	49
2024 Q3	$11M	Buy	21,158 +18	+0.1%	+$9.62K	0.43%	44
2024 Q2	$11.5M	Sell	21,140 -402	-2%	-$212K	0.44%	44
2024 Q1	$11.2M	Sell	21,542 -1,208	-5%	-$601K	0.39%	46
2023 Q4	$10.7M	Sell	22,750 -18	-0.1%	-$8.32K	0.34%	49
2023 Q3	$9.91M	Sell	22,768 -558	-2%	-$253K	0.33%	49
2023 Q2	$10.4M	Buy	23,326 +2,626	+13%	+$1.21M	0.34%	51
2023 Q1	$9.52M	Hold	20,700	–	–	0.31%	51
2022 Q4	$10.6M	Buy	20,700 +274	+1%	+$139K	0.42%	47
2022 Q3	$9.28M	Buy	+20,426	New	+$9.77M	0.42%	47

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Hardman Johnston Global Advisors's ELV Position: Q3 2025 in Review

Hardman Johnston Global Advisors sold out of Elevance Health (ELV) in Q3 2025, closing a stake of 17,588 shares — an estimated $6.84M sold.

Hardman Johnston Global Advisors first reported a position in ELV in Q3 2022 and held it in 11 quarters. The position peaked at $11.5M in Q2 2024. 1,511 funds tracked by Wall St. Rank hold ELV as of Q3 2025.

Hardman Johnston Global Advisors reported no remaining Elevance Health position as of Q3 2025 after selling out during the quarter.
Hardman Johnston Global Advisors sold 17,588 Elevance Health shares in Q3 2025, an estimated $6.84M.
Hardman Johnston Global Advisors first reported a position in Elevance Health in Q3 2022 and held it in 11 quarters.
Hardman Johnston Global Advisors's Elevance Health position peaked at $11.5M in Q2 2024.
1,511 funds tracked by Wall St. Rank held Elevance Health as of Q3 2025.

Based on Hardman Johnston Global Advisors's 13F filing for Q3 2025, filed 27 Oct 2025.